Thrombosis of second-generation drug-eluting stents in real practice: Results from the multicenter Spanish registry ESTROFA-2 (estudio espaol sobre trombosis de stents farmacoactivos de segunda generacion-2)

JACC: Cardiovascular Interventions

Volumn 3, Issue 9, 2010, Pages 911-919

  De La Torre Hernndez, Jos M ^a   Alfonso, Fernando ^b   Gimeno, Federico ^g   Diarte, Jose A ^h   Lopez Palop, Ramn ⁱ   Prez De Prado, Armando ^j   Rivero, Fernando ^c   Sanchis, Juan ^k   Larman, Mariano ^l   Diaz, Jose F ^m   Elizaga, Jaime ^d   Moreiras, Javier Martn ⁿ   Gomez Jaume, Alfredo ^o   Hernandez, Jos M ^p   Mauri, Josepa ^r   Recalde, Angel Snchez ^e   Bullones, Juan A ^q   Rumoroso, Jose R ^s   Del Blanco, Bruno Garca ^t   Baz, Jose A ^u   Bosa, Francisco ^v   Botas, Javier ^l   Hernandez, Felipe ^f   more..

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^j Hospital de Len   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^l Interventional Cardiology Department   (Spain)

^m HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^o HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^p HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^q HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^r HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^s HOSPITAL DE GALDAKAO   (Spain)

^t HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^u HOSPITAL DO MEIXOEIRO   (Spain)

^v Hospital Clínico   (Spain)

more..

Author keywords

coronary; stents; thrombosis

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS;

AGED; ARTICLE; CAROTID ARTERY BIFURCATION; CLINICAL PRACTICE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT THROMBOSIS;

AGED; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; REGISTRIES; RISK FACTORS; SPAIN;

EID: 77956632855     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.06.010     Document Type: Article

References (24)

1. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
2. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors and outcome of thrombosis after successful implantation of drug eluting stents JAMA 293 2005 2126 2130
3. P.K. Kuchulakanti, W.W. Chu, and R. Torguson Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel eluting stents Circulation 113 2006 1108 1113
4. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: results from a large two-institutional cohort study Lancet 369 2007 667 668
5. J.M. De la Torre-Hernndez, F. Alfonso, F. Hernndez ESTROFA Study Group Drug-eluting stent thrombosis: results from the multi-center Spanish registry ESTROFA (Estudio ESpaol sobre TROmbosis de stents Farmacoactivos) J Am Coll Cardiol 51 2008 986 990
6. P. Wenaweser, J. Daemen, and M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice J Am Coll Cardiol 52 2008 1134 1140
7. J. Fajadet, W. Wijns, G.J. Laarman ENDEAVOR II Investigators Randomized, double blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for the treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806
8. D.E. Kandzari, M.B. Leon, J.J. Popma ENDEAVOR III Investigators Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial J Am Coll Cardiol 48 2006 2440 2447
9. M.B. Leon, L. Mauri, J.J. Popma ENDEAVOR IV Investigators A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions. 12 month outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554
10. P.W. Serruys, P. Ruygrook, and J. Neuzner A randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
11. G.W. Stone, M. Midei, W. Newman SPIRIT III Investigators Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913
12. G.W. Stone, M. Midei, W. Newman SPIRIT III Investigators Randomized comparison of everolimus-eluting and paclitaxel-eluting stents Two year clinical follow up from the clinical evaluation of the Xience V everolimus-eluting coronary stent system in the treatment of patients with the novo native coronary artery lesions SPIRIT III trial Circulation 119 2009 680 686
13. E. Kedhi, K.S. Joesoef, and E. McFadden Second generation everolimus-eluting stent and paclitaxel eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
14. K. Rasmussen, M. Maeng, A. Kaltoft SORT OUT III Study Group Efficacy and safety of zotarolimus-eluting stent and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomized controlled superiority trial Lancet 375 2010 1090 1099
15. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stents trialsa case for standardized definitions Circulation 115 2007 2344 2351
16. R. Jaffe, and B.H. Strauss Late and very late thrombosis of drug-eluting stents Evolving concepts and perspectives J Am Coll Cardiol 50 2007 119 127
17. M. Joner, G. Nakazawa, and A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342
18. R. Sakurai, H.N. Bonneau, Y. Honda, and P.J. Fitzgerald Intravascular ultrasound findings in ENDEAVOR II and ENDEAVOR III Am J Cardiol 100 Suppl 8B 2007 71M 76M
19. G. Guagliumi Optical coherence tomography for DES safety (ODESSA trial) Paper presented at: Transcatheter Therapeutics September 2008 Washington, DC http://www.tctmd.com/show.aspx?id=69992 Accessed May 15, 2010
20. A. Gershlick, D.E. Kandzari, M.B. Leon ENDEAVOR Investigators Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1317 patients Am J Cardiol 100 Suppl 8B 2007 45M 55M
21. R. Miu, P.W. Serruys, and G.W. Stone Performance of everolimus-eluting stents: pooled analysis from the SPIRIT trials J Interven Cardiol 22 2009 S41 S47
22. G.W. Stone SPIRIT IV. A prospective, randomized trial comparing an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease One year clinical results. Paper presented at: Transcatheter Therapeutics September 2009 San Francisco, CA http://www.tctmd. com/show.aspx?id=84104 Accessed May 15, 2010
23. Y. Onuma, N. Kukreja, N. Piazza Interventional Cardiologists of the Thoraxcenter (2000 to 2007) The everolimus-eluting stent in real world patients. 6 month follow up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) Registry J Am Coll Cardiol 54 2009 269 276
24. C. Lotan, I.T. Meredith, L. Mauri, M. Liu, M.T. Rothman E-Five Investigators Safety and effectiveness of the Endeavour zotarolimus-eluting stent in real-world clinical practice: 12 month data from the E-Five registry J Am Coll Cardiol Intv 2 2009 1227 1235